Turin Christie G, Joeng Kyu Sang, Kallish Staci, Raper Anna, Asher Stephanie, Campeau Philippe M, Khan Amna N, Al Mukaddam Mona
Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., 4th floor, Philadelphia, PA 19104, USA.
Mckay Orthopaedic Research Laboratory and Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, 3450 Hamilton Walk, Philadelphia, PA 19104, USA.
Bone Rep. 2021 Aug 18;15:101118. doi: 10.1016/j.bonr.2021.101118. eCollection 2021 Dec.
Osteoporosis is a multifactorial disorder characterized by low bone mass and strength, leading to increased risk of fracture. The WNT pathway plays a critical role in bone remodeling by enhancing osteoblastic differentiation, which promotes bone formation, and inhibiting osteoclastic differentiation, decreasing bone resorption. Therefore, genetic alterations of this pathway will lead to impaired bone homeostasis and could contribute to varying response to treatment. We present the case of two brothers with early osteoporosis who were found to have a heterozygous variant of unknown significance in the gene, c.1060_1061delCAinsG (p.H354Afs*39). This finding demonstrates that frameshift variants in may also act in a dominant fashion leading to decreased bone mass.
骨质疏松症是一种多因素疾病,其特征是骨量和骨强度降低,导致骨折风险增加。WNT信号通路通过增强促进骨形成的成骨细胞分化和抑制导致骨吸收减少的破骨细胞分化,在骨重塑中起关键作用。因此,该信号通路的基因改变将导致骨稳态受损,并可能导致对治疗的不同反应。我们报告了两兄弟患有早期骨质疏松症的病例,他们被发现该基因存在一个意义不明的杂合变异,即c.1060_1061delCAinsG(p.H354Afs*39)。这一发现表明,该基因的移码变异也可能以显性方式起作用,导致骨量减少。